Viking Therapeutics Inc’s recently made public that its Director MACARTNEY LAWSON unloaded Company’s shares for reported $0.14 million on Nov 08 ’24. In the deal valued at $68.67 per share,2,000 shares were sold. As a result of this transaction, MACARTNEY LAWSON now holds 47,965 shares worth roughly $2.42 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, LAWSON MACARTNEY bought 2,000 shares, generating $137,333 in total proceeds.
Before that, ZANTE GREG sold 131,687 shares. Viking Therapeutics Inc shares valued at $10,089,164 were divested by the Chief Financial Officer at a price of $76.61 per share. As a result of the transaction, ZANTE GREG now holds 149,366 shares, worth roughly $7.52 million.
Piper Sandler initiated its Viking Therapeutics Inc [VKTX] rating to an Overweight in a research note published recently. A number of analysts have revised their coverage, including B. Riley Securities’s analysts, who began to cover the stock in late November with a ‘”a Buy”‘ rating. H.C. Wainwright also remained covering VKTX and reiterated its “Buy” recommendation on November 04, 2024. JP Morgan started covering the stock on September 11, 2024. It rated VKTX as “an Overweight”.
Price Performance Review of VKTX
On Monday, Viking Therapeutics Inc [NASDAQ:VKTX] saw its stock fall -0.89% to $50.35. Over the last five days, the stock has lost -2.25%. Viking Therapeutics Inc shares have risen nearly 170.55% since the year began. Nevertheless, the stocks have risen 179.10% over the past one year. While a 52-week high of $99.41 was reached on 02/28/24, a 52-week low of $16.70 was recorded on 01/03/24. SMA at 50 days reached $61.12, while 200 days put it at $63.30.
Levels Of Support And Resistance For VKTX Stock
The 24-hour chart illustrates a support level at 49.61, which if violated will result in even more drops to 48.86. On the upside, there is a resistance level at 51.39. A further resistance level may holdings at 52.42. The Relative Strength Index (RSI) on the 14-day chart is 37.86, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.38, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 70.23%. Stochastics %K at 30.78% indicates the stock is a holding.
How much short interest is there in Viking Therapeutics Inc?
A steep rise in short interest was recorded in Viking Therapeutics Inc stocks on 2024-11-15, growing by 2.6 million shares to a total of 16.99 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 14.39 million shares. There was a rise of 15.3%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on June 27, 2024 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $105 price target.
